If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £111.95m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Warwick Acoustics Update

7 Oct 2020 07:00

RNS Number : 2990B
Mercia Asset Management PLC
07 October 2020
 

 

RNS REACH

7 October 2020

 

Mercia Asset Management PLC

("Mercia" or "the Group")

 

Warwick Acoustics Update

 

£2.1million of syndicated investment and £0.4million innovation grant

 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused, specialist asset manager with c.£800 million of assets under management, is pleased to announce that its direct portfolio company Warwick Acoustics Limited ("Warwick Acoustics", "the Company") has secured £2.1million of recent syndicated investment, including £0.5million from Mercia. The Company has also recently won a £0.4million grant from Innovate UK, in conjunction with the University of Warwick.

 

Warwick Acoustics is one of Mercia's earliest investments, having received its first investment through Mercia's managed funds in January 2013 before becoming a balance sheet direct investment in December 2014. As at 31 March 2020, Mercia held a 52.9% fully diluted direct holding in Warwick Acoustics.

 

The Company, which is based in state-of-the-art facilities at the Mira Technology Park in Warwickshire, develops highly innovative audio products for both the automotive audio market and the personal and studio headphone market.

 

Despite the challenges in the automotive industry as a result of the COVID-19 pandemic, Warwick Acoustics is continuing to make good progress in both the automotive and headphone markets.

 

Reflective of this progress the Company was recently awarded a grant from Innovate UK to support the development of lower cost designs for its lightweight, highly power-efficient ElectroAcoustic Panels. Targeted manufacturing cost reductions will enable the Company to significantly expand the reach of its technology from premium to mass market vehicles.

 

Combined, this significant funding provides sufficient development capital to support the Company's expansion plans for at least the next 15 months.

 

Mike Grant, Chief Executive Officer at Warwick Acoustics, commented: 

"The COVID-19 pandemic has created new challenges for the automotive industry. Government regulations and new cash flow pressures are requiring OEMs to rationalise model ranges to reduce costs and to focus on accelerating developments of Electric Vehicles ("EVs"). This in turn has placed a premium on light-weighting and power-efficient technologies in order to increase range and improve the attractiveness of EVs.

 

"The recent investment in Warwick Acoustics and the award of an Innovate UK grant under highly competitive conditions recognise the class leading weight savings and power efficiency of our high- performance, patented ElectroAcoustic Panel technology. With this combined funding, we are in an excellent position to take the next step in our goal of disrupting the way in which in-car entertainment is delivered."

 

Mark Payton, Chief Executive Officer at Mercia, commented: 

"We believe Warwick Acoustics has a compelling product set and is well positioned to capitalise on both the increasing demands from the automotive industry for smaller, lightweight, quality audio as well as similar trends from consumers. We are pleased to continue supporting the business in delivering on these commercial opportunities through a meaningful syndication. Businesses such as Warwick Acoustics have significant potential to help the automotive industry by reducing weight, space and costs within an emission-focused regulatory environment. We therefore continue to be encouraged by the business's significant potential to assist the increasingly innovative automotive industry."

 

-Ends-

 

For further information, please contact:

 

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

 

+44 (0)330 223 1430

 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel, Richard Andrews

 

 

 

N+1 Singer (Joint Broker)

 

Harry Gooden, James Moat

 

+44 (0)20 7496 3000

 

 

FTI Consulting

 

 +44 (0)20 3727 1051

Tom Blackwell, Louisa Feltes, Shiv Talwar

 

mercia@fticonsulting.com

 

 

About Mercia Asset Management PLC:

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

 

The Group has a strong UK footprint through its regional offices, 19 university partnerships and extensive personal networks, providing it with access to high-quality deal flow. Mercia currently has c.£800million of assets under management and, since its IPO in December 2014, has invested over £96million into its direct investment portfolio.

 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFITIFLRIII
Date   Source Headline
22nd Nov 20217:00 amRNSInvestor Presentation
2nd Nov 20217:00 amRNSMercia announces a new direct investment
27th Oct 20217:00 amRNSNotice of Interim Results
26th Oct 20217:00 amRNSMercia announces new direct investment
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.